Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials-Reference-Cited by-同舟云学术

Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials

Published:2023-01-04 Issue:1 Volume:50 Page:45-62
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Muralidharan Kumar Kandadi^ORCID,Kowalski Kenneth G.,Tong Xiao,Haeberlein Samantha Budd,Rajagovindan Rajasimhan,Nestorov Ivan

Funder

Biogen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s10928-022-09839-3.pdf

Reference18 articles.

1. Alzheimer’s Association (2021) What is Alzheimer’s disease? https://www.alz.org/alzheimers-dementia/what-is-alzheimers. Accessed 24 Aug 2021

2. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356. https://doi.org/10.1126/science.1072994

3. Hock C, Konietzko U, Streffer JR et al (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer’s disease. Neuron 38:547–554. https://doi.org/10.1016/s0896-6273(03)00294-0

4. Sevigny J, Chiao P, Bussière T et al (2016) The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537:50–56. https://doi.org/10.1038/nature19323

5. Budd Haeberlein S, Aisen P, Barkhof F et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis 9:197–210. https://doi.org/10.14283/jpad.2022.30

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS);The AAPS Journal;2024-04-30

2. Global biomarker trends in Alzheimer’s research: A bibliometric analysis;Drug Discovery Today;2023-08

3. Correction to: Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials;Journal of Pharmacokinetics and Pharmacodynamics;2023-03-04